Operator: Good morning, everyone, and welcome to the United Therapeutics Corporation Third Quarter 2025 Corporate Update. My name is Jamie, and I will be your conference operator today.
[Operator Instructions]
Please also note today’s event is being recorded. At this time, I’d like to turn the floor over to Harry Silvers, Investor Relations Manager at United Therapeutics.
—
**Harrison Silvers, Manager of Investor Relations:**
Thank you, Jamie. Good morning. It is my pleasure to welcome you to the United Therapeutics Corporation Third Quarter 2025 Corporate Update Webcast.
Remarks today will include forward-looking statements representing our expectations or beliefs regarding future events. These statements involve risks and uncertainties that may cause actual results to differ materially.
Our latest SEC filings, including Forms 10-K and 10-Q, contain additional information on these risks and uncertainties. We assume no obligation to update forward-looking statements.
Today’s remarks may also discuss the progress and results of clinical trials or other developments with respect to our products. These remarks are intended solely to educate investors and are not intended to serve as the basis for medical decision-making or to suggest that any products are safe and effective for any unapproved or investigational uses.
Full prescribing information for the products is available upon request.
https://seekingalpha.com/article/4834678-united-therapeutics-corporation-uthr-q3-2025-earnings-call-transcript?source=feed_all_articles
Be First to Comment